Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Adrafinil is a non-peptide synthetic eugeroic (wakefulness-promoting agent) and diphenylmethylsulfinyl-acetohydroxamic acid derivative that functions as a prodrug of modafinil. It was approved in France (marketed as Olmifon) from 1984 to 2011 for narcolepsy but was voluntarily withdrawn due to hepatotoxicity concerns and an unfavorable risk-benefit ratio. Adrafinil is not currently approved in any jurisdiction; the FDA classifies it as an unapproved new drug when sold as a dietary supplement. It is prohibited in competitive sport under WADA’s S6.a Non-Specified Stimulants category.
Verified purity per dollar — the cheapest that's actually been tested
No prices found for Adrafinil.
Single-vial list prices by default for a fair head-to-head — switch to Multi-vial / bulk for pack pricing. Estimates only; verify at vendor before purchase. For research use only. Not medical advice.
Kimera Chems has the lowest single-vial Adrafinil price at $0.006/mg among 3 COA-verified vendors on Disclosed Labs. Bulk or multi-vial deals may be lower.
What is the price range for Adrafinil?
Research-grade Adrafinil is listed at $0.006/mg from 1 verified source on Disclosed Labs.
How are Adrafinil prices verified on Disclosed Labs?
Every listed vendor holds a Grade C or better trust score, computed independently from lab Certificates of Analysis — not from payments or sponsorships. Prices are scraped and fact-checked daily. Vendors cannot pay to improve their ranking.
Check formulation: Lyophilized powder requires reconstitution before use. Pre-mixed solutions are more convenient but may have a shorter shelf life and higher prices.
Compare per-mg cost: Different strengths and quantities make direct price comparison difficult. Calculate the per-milligram cost to find the true best value.
Verify COAs: Look for vendors that publish per-batch Certificates of Analysis from named, accredited labs. Use the Full safety panel filter to require endotoxin, sterility, and heavy-metals testing on the current batch — not just HPLC purity.
Adrafinil was approved in France for narcolepsy (1985) after initial human testing in 1977–1978, but was voluntarily withdrawn in September 2011 due to hepatotoxicity concerns and an unfavorable risk-benefit ratio. No current registered interventional clinical trials exist; the only registered study is an observational survey listing adrafinil as a queried substance. One published forensic study (n=1) detected adrafinil (0.8 ng/mg) and modafinil (0.5 ng/mg) in beard hair 10 days after a single 200 mg oral dose in one adult volunteer. Preclinical studies in aged beagle dogs found oral 20 mg/kg adrafinil improved discrimination learning but impaired working memory in a delayed nonmatching-to-position task over 8 days. Rat studies of the metabolite modafinil showed dose-dependent increases in locomotor activity and extracellular dopamine.
This platform provides informational tools only, not medical advice.
Prices verified as of July 2026. Actual prices may vary. For research use only.
2000